Instem has partnered with Proscia. Through the collaboration, the companies will deliver a unified customer experience around Instem?s Provantis preclinical study management solution and Proscia?s Concentriq for Research software platform to accelerate toxicologic pathology and other preclinical studies. The unified customer experience will center on a joint product integration that seamlessly incorporates Provantis users?

data into Concentriq for Research's purpose-built digital pathology workflows. In doing so, the integration will enable them to speed up primary and peer review assessments, streamline collaboration, and simplify GLP compliance in one software platform so they can conduct regulated and non-regulated studies faster and make more informed decisions. Concentriq is trusted by 14 of the top 20 pharmaceutical companies as well as leading contract research organizations.

In entering into this collaboration, Instem will also join the Proscia Ready partner alliance, furthering the companies? commitment to customer experience. Proscia Ready is made up of solution providers helping laboratories and life sciences organizations accelerate the scaled adoption of digital pathology with confidence.

It delivers on this aim through a shared focus on product integration, joint support agreements, and a collective vision for future innovation.